Ventripoint To Present Its AI-enhanced Cardiac Ultrasound Ventripoint To Present Its AI-enhanced Cardiac Ultrasound
Technology to B.C. and Canadian Health Care Leaders at The
Data Effect
For Immediate Release
Toronto, Ontario – June 24, 2024 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the
"Company"), (TSXV:VPT; OTC:VPTDF) has been selected to present its AI-enhanced cardiac
ultrasound technology, which generates MRI-quality cardiac measurements in minutes, to
health-care leaders at The Data Effect on June 25th in Vancouver.
CEO Hugh MacNaught will be on the panel Accelerating AI Startups in Canadian Health
Care, which explores applications of AI and digital health with global impact.
He is being joined on this panel at The Data Effect by other health care leaders, including:
Maryam Sadeghi PhD, CEO & Co-Founder of MetaOptima; Lloyd Jura, a Professor specializing
in AI and cybersecurity at New York Institute of Technology; Tiffany Chiu, AbCellera’s VicePresident of Communications; and the Vancouver-based innovator Dr. Alexandra T
Greenhill, CEO of CareTeam Technologies.
“This is an important forum to meet the innovators as well as the health care and hospital
thought leaders who are at the lead of bringing new approaches to data and AI to provincial
health care systems,” said MacNaught. “We are delighted to have been invited to The Data
Effect, as we introduce Ventripoint innovations to hospitals around Canada and the world.”
Ventripoint’s VMS+ easily interfaces with all major brands of echocardiography machines and
transforms 2D ultrasound scans into 3D images of all four chambers of the heart more rapidly
and at less expense than cardiac MRI. VMS+ has received clearance by FDA, and is licensed
for sale by Health Canada and regulators in the UK and EU. It is now being used in leading
hospitals in Canada, the US, Germany and the UK.
The Data Effect has been gathering Canada’s health care leaders together for more than a
decade, to highlight technologies and ideas to improve health care for caregivers and patients.
The Vancouver Data Effect, part of an ongoing series looking at AI and data in health care and
other sectors, is being attended by more than 125 health care leaders.
The focus of the Vancouver conference is on how Canadian technologies, data and AI can
advance health care solutions and patient care. It is part of The Data Effect ‘s stated mission to
bring together leaders and technologies to “explore how new approaches in health data
stewardship and AI – in combination with innovations in health campus design and life science
research – can drive better health services in Canada and build our global profile.“